secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyteir Therapeutics, Inc. (—)
CIK:        0001662244
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0000950170-24-034247
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyteir Therapeutics files certificate of dissolution; estimates $3.10-$3.16 per share liquidation distribution
--------------------------------------------------------------------------------

- Filed Certificate of Dissolution with Delaware Secretary of State on March 20, 2024, dissolving the company.
- Record date set as March 20, 2024 for liquidation distributions; stock transfer books closed immediately.
- Estimated aggregate cash distribution between $3.10 and $3.16 per share, with first payment expected in Q2 2024.
- Terminated Amended and Restated 2012 Stock Incentive Plan, 2021 Equity Incentive Plan, and Employee Stock Purchase Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662244/000095017024034247/0000950170-24-034247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662244/000095017024034247/cyt-20240320.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-034247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer